High Court finds Sandoz infringed Lundbeck’s Lexapro patent
Angus Lang
2022-03-09 4:40 pm
| Sydney
The High Court has found that Novartis unit Sandoz infringed Danish drug company Lundbeck’s patent for its blockbuster antidepressant Lexapro, but has overturned a ruling that found the generic drug maker owes $26.3 million in damages.
For information on rights and reprints, contact subscriptions@lawyerly.com.au